Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Contreras

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|August 4, 1987
Selective memory impairment by phencyclidine in ratsG E Handelmann, P C Contreras, T L O'Donohue
Progress in Clinical and Biological Research|January 1, 1985
Evidence for an endogenous peptide ligand and antagonist for PCP receptorsP C Contreras, D A DiMaggio, T L O'Donohue
Synapse (New York, N.Y.)|January 1, 1987
An endogenous ligand for the sigma opioid binding siteP C Contreras, D A DiMaggio, T L O'Donohue
Life Sciences|January 1, 1990
GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brainP C Contreras, M E Bremer, T S Rao
Brain Research|February 26, 1993
[3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptorsP C Contreras, L Tam, E Drower, et al.
Regulatory Toxicology and Pharmacology : RTP|April 22, 2015
Carcinogenicity assessment of the pan-caspase inhibitor, emricasan, in Tg.rasH2 miceR H Elbekai, M G Paranjpe, P C Contreras, et al.
NIDA Research Monograph|January 1, 1986
Isolation and identification of an endogenous ligand for the phencyclidine receptorD A DiMaggio, P C Contreras, R Quirion, et al.
Ciba Foundation Symposium|January 1, 1996
Potential utility of rhIGF-1 in neuromuscular and/or degenerative diseaseJ L Vaught, P C Contreras, M A Glicksman, et al.
Life Sciences|January 1, 1990
H1 antihistamines interact with central sigma receptorsN M Gray, P C Contreras, S E Allen, et al.
Life Sciences|January 1, 1992
BMY-14802 protects against ischemia-induced neuronal damage in the gerbilP C Contreras, N M Gray, D M Ragan, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|August 4, 1987
Selective memory impairment by phencyclidine in ratsG E Handelmann, P C Contreras, T L O'Donohue
Progress in Clinical and Biological Research|January 1, 1985
Evidence for an endogenous peptide ligand and antagonist for PCP receptorsP C Contreras, D A DiMaggio, T L O'Donohue
Synapse (New York, N.Y.)|January 1, 1987
An endogenous ligand for the sigma opioid binding siteP C Contreras, D A DiMaggio, T L O'Donohue
Life Sciences|January 1, 1990
GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brainP C Contreras, M E Bremer, T S Rao
Brain Research|February 26, 1993
[3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptorsP C Contreras, L Tam, E Drower, et al.
Regulatory Toxicology and Pharmacology : RTP|April 22, 2015
Carcinogenicity assessment of the pan-caspase inhibitor, emricasan, in Tg.rasH2 miceR H Elbekai, M G Paranjpe, P C Contreras, et al.
NIDA Research Monograph|January 1, 1986
Isolation and identification of an endogenous ligand for the phencyclidine receptorD A DiMaggio, P C Contreras, R Quirion, et al.
Ciba Foundation Symposium|January 1, 1996
Potential utility of rhIGF-1 in neuromuscular and/or degenerative diseaseJ L Vaught, P C Contreras, M A Glicksman, et al.
Life Sciences|January 1, 1990
H1 antihistamines interact with central sigma receptorsN M Gray, P C Contreras, S E Allen, et al.
Life Sciences|January 1, 1992
BMY-14802 protects against ischemia-induced neuronal damage in the gerbilP C Contreras, N M Gray, D M Ragan, et al.
Pageof 7